ixekizumab,adalimumab,secukinumab
eli lilly,abbvie,novartis
['secukinumab', ' psa', 'adalimumab', 'ixekizumab']
 the studies that established efficacy for il-17a inhibitors in psa tx secukinumab - future 2 ixekizumab - spirit-p1 (adalimumab was not compared head to head, nb) #acr22 #reviewcourse 
@bu_bmc_rheum | @rheum_covid @spartan_updates @official_asas | @UWRheum @UWEpidemiology 2020 | @OHSUIMres 2017 | @UTMBhealth 2014 | @UTAustin 2010